Cytomx Therapeutics Stock Widgets and Gadgets
| CTMX Stock | USD 1.09 0.03 2.83% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CTMX CytomX Therapeutics
- Latest JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer
- CTMX 1.09 0.03
- Low 1.03
- High 1.16
- Volume 1.5 M
- Alpha -0.24
- Beta 1.29
- Return On Equity -54.75
- Return On Asset 0.0233
- Profit Margin 0.11 %
- Operating Margin 0.12 %
- Current Valuation (24.04 M)
- Shares Outstanding 78.26 M
- Shares Owned By Insiders 1.00 %
- Shares Owned By Institutions 65.62 %
- Number Of Shares Shorted 4.44 M
- Price To Earning (11.41) X
- Price To Book 5.04 X
- Price To Sales 0.66 X
- Revenue 101.21 M
- Gross Profit 53.16 M
- EBITDA (4.31 M)
- Net Income (569 K)
- Cash And Equivalents 194.29 M
- Cash Per Share 2.94 X
- Total Debt 13.97 M
- Debt To Equity 0.67 %
- Current Ratio 2.05 X
- Book Value Per Share (0.30) X
- Cash Flow From Operations (56.03 M)
- Short Ratio 4.41 X
- Earnings Per Share 0.16 X
- Price To Earnings To Growth (1.80) X
- Target Price 5.29
- Number Of Employees 120
- Beta 1.06
- Market Capitalization 82.95 M
- Total Asset 201.79 M
- Retained Earnings (723.45 M)
- Working Capital 27.02 M
- Current Asset 189.75 M
- Current Liabilities 15.74 M
- Net Asset 201.79 M
- Accumulation Distribution 164472.0
- Daily Balance Of Power 0.2308
- Rate Of Daily Change 1.03
- Day Median Price 1.1
- Day Typical Price 1.09
- Price Action Indicator 0.01
- Period Momentum Indicator 0.03
Market Snapshot Widget Example
DAX Index Germany | 19,934 1.57 | |
Taiwan Weighted Taiwan | 22,737 2.13 | |
PSI 20 Stock Portugal | 6,363 0.87 | |
CROBEX Croatia | 3,158 0.11 | |
Budapest SE Hungary | 78,204 0.34 | |
IDX 30 Jakarta Indonesia | 431.39 1.67 | |
ISEQ 20 Price Ireland | 1,612 0.06 | |
NYSE Comp USA | 20,213 0.29 | |
Tel Aviv 35 Israel | 2,293 1.42 | |
Coreshares Index Tracker South Afric | 1,105 2.31 | |
IPC MEXICO Mexico | 50,433 1.45 | |
KL Technology Malaysia | 59.14 1.13 | |
IBEX 35 Index Spain | 11,735 0.81 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,536 0.11 | |
SPASX Dividend Opportunities Australia | 1,704 0.41 | |
HNX 30 Vietnam | 481.92 0.44 | |
Bucharest BET-NG Romania | 1,176 1.41 | |
AMS Small Cap Netherlands | 1,227 0.05 | |
Oslo Exchange Mutual Norway | 1,410 0.03 | |
BEL Small Belgium | 7,991 0.27 | |
Basic Materials Brazil | 5,891 0.28 | |
Swiss Leader Price Switzerland | 1,951 0.51 | |
Fondo Mutuo ETF Chile | 1,375 0.54 | |
Athens General Comp Greece | 1,424 2.21 | |
Stock Exchange Of Thailand | 1,437 0.67 | |
PX Prague Stock Czech Repub | 1,682 0.33 | |
THE PHILIPPINE STOCK Philippines | 6,743 1.95 | |
WIG 30 Poland | 2,877 2.43 | |
BIST Electricity Turkey | 492.42 0.31 |
Investing Ideas
In addition to having CytomX Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare CytomX Therapeutics
Compare CytomX Therapeutics To Peers
Additional Tools for CytomX Stock Analysis
When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.